Global Vision Announces Partnership with Israeli Reseller Dor Pharmaceutical Services

Global Vision’s proofreading technologies now available to support the growing demand from pharmaceutical companies in Israel  Montreal, CANADA, and Kfar-Saba, ISRAEL, March 18, 2015 – Global Vision, the world leader in the development of innovative proofreading technologies, today announced the expansion of its operations in Israel through a reseller agreement with Dor Pharmaceutical Services, a leading provider of solutions to the pharmaceutical and medical device marketplace. The Israeli marketplace has high levels of adoption of proofreading technologies with a growth rate estimated in excess of 3% annually. Pharmaceutical and medical device companies throughout Israel, now have access to Global Vision’s complete suite of products that include text-based, pixel-based, barcode and Braille inspection solutions. “Israel is known for its vibrant pharmaceutical and medical device industry, and we are eager to take the next step in serving this exciting market with solutions like Proofware, the world’s first web-based packaging inspection suite,” explained Reuben Malz, President of Global Vision. “By partnering with Dor Pharmaceutical Services, we can better address the requirements of pharmaceutical and medical device customers in Israel and tailor solutions that meet their specific needs.” “At Dor Pharmaceutical Services, we pride ourselves in providing leading-edge high quality professional services for pharmaceutical and medical device companies in regulatory affairs, quality assurance, clinical trials, pharmacovigilance and labelling localisation” said Rami Mittleman, COO, Dor Pharmaceutical Services. “We are highly impressed by Global Vision solutions, their performance and reliability, and are excited to expand the adoption of these powerful technologies in the Israeli market.” Leader in proofreading technologies for 25 years See for yourself why 72% of all pharmaceutical companies worldwide have implemented Global...